Sfoglia per Autore
Functional impact of Toll-like Receptor 4 (TLR4) modulation in lung fibrosis-associated fibroblasts
2025 Italia, A; Romerio, A; Lami, F; Sarcinelli, G; Lenoci, M; Galli, M; Granucci, F; Costa, B; Lovisa, S; Peri, F
Renewable proteins from agricultural and animal sources as innovative multifunctional bio-fillers for rubber composites: A comprehensive review
2025 Alagia, M; La Ferla, B; Zoia, L; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2025 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Preclinical development of the TLR4 antagonist FP12 as a drug lead targeting the HMGB1/MD-2/TLR4 axis in lethal influenza infection
2025 Shirey, K; Romerio, A; Shaik, M; Leake, D; Palmer, C; Skupinska, N; Paton, J; Pirianov, G; Blanco, J; Vogel, S; Peri, F
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa Challenge
2025 Sainz-Mejias, M; Ma, C; Hou, Y; Jurado-Martin, I; Romerio, A; Franco, A; Shaik, M; Tomas-Cortazar, J; Peri, F; Mcclean, S
Effects of the green cross-linking agent tannic acid and its oxidation on the properties of porcine plasma protein superabsorbent materials
2025 Alagia, M; Bengoechea, C; La Ferla, B; Peri, F; Guerrero, A
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonists
2025 Franco, A; Aladailleh, Z; Romerio, A; Italia, A; Lami, F; Shaik, M; Skupinska, N; Artusa, V; Pirianov, G; Peri, F
Design, Synthesis and characterization of synthetic and natural derived TLR4 antagonists
2024 Lami, F; Romerio, A; Italia, A; Shaik, M; Martin-Santamaria, S; Peri, F
Istaroxime follow-on compounds: A new class of selective SERCA2a activators for chronic heart failure treatment
2024 Arici, M; Hsu, S; Ferrandi, M; Barassi, P; Ronchi, C; Torre, E; Luraghi, A; Metallo, A; Chang, G; Ferrari, P; Bianchi, G; Regonesi, M; Airoldi, C; Peri, F; Zaza, A; Rocchetti, M
A new advanced cellular model of functional cholinergic-like neurons developed by reprogramming the human SH-SY5Y neuroblastoma cell line
2024 D'Aloia, A; Pastori, V; Blasa, S; Campioni, G; Peri, F; Sacco, E; Ceriani, M; Lecchi, M; Costa, B
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding Antibodies
2024 Franco, A; Sadones, O; Romerio, A; Artusa, V; Shaik, M; Pasco, S; Italia, A; D'Amato, S; Anguita, J; Huebner, J; Romero-Saavedra, F; Peri, F
Study on the impact of Toll-like Receptor 4 (TLR4) modulation in rare inflammatory-fibrotic diseases
2024 Italia, A; Franco, A; Shaik, M; Romerio, A; Lami, F; Lovisa, S; Peri, F; Costa, B
Selective SERCA2a activator as a candidate for chronic heart failure therapy
2024 Arici, M; Hsu, S; Ferrandi, M; Barassi, P; Ronchi, C; Torre, E; Luraghi, A; Chang, G; Ferrari, P; Bianchi, G; Peri, F; Zaza, A; Rocchetti, M
Development of a New Vaccine Adjuvant System Based on the Combination of the Synthetic TLR4 Agonist FP20 and a Synthetic QS-21 Variant
2024 Shaik, M; Pasco, S; Romerio, A; Pifferi, C; Sesana, S; Re, F; Bezuidenhout, C; Bracco, S; Fernandez-Tejada, A; Anguita, J; Peri, F
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonists
2024 Ami, D; Franco, A; Artusa, V; Romerio, A; Shaik, M; Italia, A; Anguita, J; Pasco, S; Mereghetti, P; Peri, F; Natalello, A
New Glucosamine-Based TLR4 Agonists: Design, Synthesis, Mechanism of Action, and In Vivo Activity as Vaccine Adjuvants
2023 Romerio, A; Gotri, N; Franco, A; Artusa, V; Shaik, M; Pasco, S; Atxabal, U; Matamoros-Recio, A; Minguez-Toral, M; Zalamea, J; Franconetti, A; Abrescia, N; Jimenez-Barbero, J; Anguita, J; Martin-Santamaria, S; Peri, F
Use of Fluorescent Chemical Probes in the Study of Toll-like Receptors (TLRs) Trafficking
2023 Franco, A; Artusa, V; Peri, F
Cleaner synthesis of preclinically validated vaccine adjuvants
2023 Romerio, A; Peri, F
Istaroxime Metabolite PST3093 Selectively Stimulates SERCA2a and Reverses Disease-Induced Changes in Cardiac Function
2023 Arici, M; Ferrandi, M; Barassi, P; Hsu, S; Torre, E; Luraghi, A; Ronchi, C; Chang, G; Peri, F; Ferrari, P; Bianchi, G; Rocchetti, M; Zaza, A
Emerging Extracellular Molecular Targets for Innovative Pharmacological Approaches to Resistant Mtb Infection
2023 Italia, A; Shaik, M; Peri, F
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile